The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Screening for Thyroid Disease: An Update
Abstract
PURPOSE: To review information on the benefits of screening with a sensitive thyroid-stimulating hormone (TSH) test for thyroid dysfunction in asymptomatic patients seeking primary care for other reasons. This paper focuses on whether screening should be aimed at detection of subclinical thyroid dysfunction and whether persons with mildly abnormal TSH levels can benefit. DATA SOURCES: A MEDLINE search for studies of screening for thyroid dysfunction and of treatment for complications of subclinical thyroid dysfunction. STUDY SELECTION: Studies of screening with thyroid function tests in the general adult population or in patients seen in the general office setting were selected (n=33). All controlled studies of treatment in patients with subclinical hypothyroidism or subclinical hyperthyroidism were also included (n=23). DATA EXTRACTION: The prevalence of overt and subclinical thyroid dysfunction, the evidence for the efficacy of treatment, and the incidence of complications in defined age and sex groups were extracted from each study. DATA SYNTHESIS: Screening can detect symptomatic but unsuspected overt thyroid dysfunction. The yield is highest for women older than 50 years of age: In this group, 1 in 71 women screened could benefit from relief of symptoms. Evidence of the efficacy of treatment for subclinical thyroid dysfunction is inconclusive. CONCLUSIONS: Even though treatment for subclinical thyroid dysfunction is controversial, office-based screening to detect overt thyroid dysfunction may be indicated in women older than 50 years of age. Large randomized trials are needed to determine the likelihood that treatment will improve quality of life in otherwise healthy patients who have mildly elevated TSH levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review of studies that evaluated screening for the thyroid disease in the primary care setting in 1998 concluded that opportunistic screening of women aged >50 years may be beneficial but again called for large, randomised trials to validate the use of population screening for subclinical hypothyroidism [66].”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [66]
In the citing paper
“There is less of a consensus regarding screening of the population for undiagnosed thyroid disease, which may be common among the general population.”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [66]
Citations
Cites
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
TUNBRIDGE, W. M. G., EVERED, D. C., HALL, R., APPLETON, D., BREWIS, M., CLARK, F., EVANS, J. G., YOUNG, E., BIRD, T., & SMITH, P. A. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,674 · cited 4×
“Such patients almost always have symptoms that are relieved by treatment (8, 23 ).”
InfluentialThe incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432 · cited 2×
“A logistic regression equation de veloped by the Whickham investigators can be used to estimate risk in these groups ( 54 ).”
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681 · cited 1×
“The inverse of this dif ference is the number needed to treat (NNT) to benefit one patient ( 6 ).”
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 3×
“Fifteen percent to 50% of patients receiving L-thyroxine for primary hypothyroidism are uninten tionally maintained on doses sufficient to cause the TSH level to be undetectable ( 38 , 68, 69).”
InfluentialUsers' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations
Guyatt, G. H. (1995) · JAMA · doi:10.1001/jama.1995.03530220066035 · Cited by 846 · cited 1×
“Preventive Task Force sys tem (46) or level C in the system used by Hayward and colleagues (72, 73 ), reflecting the lack of direct evidence from randomized trials about the out comes of screening.”
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567 · cited 10×
“screening to have subclinical hypothyroidism have at least one symptom that could be related to this diagnosis ( 11 , 13).”
InfluentialGuide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-720_2 · Cited by 543
L-Thyroxine Therapy in Subclinical Hypothyroidism: A Double-Blind, Placebo-Controlled Trial
COOPER, D. S., HALPERN, R., WOOD, L. C., LEVIN, A. A., & RIDGWAY, E. C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-18 · Cited by 423
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398 · cited 1×
“A well-done meta-analysis ( 70 ) found that suppressive doses of L-thyroxine caused small (5% to 9%) but statistically significant decreases in bone density of the spine, femoral neck, distal radius, and trochanter.”
NYSTRÖM, E., CAIDAHL, K., FAGER, G., WIKKELSÖ, C., LUNDBERG, P. ‐., & LINDSTEDT, G. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb00250.x · Cited by 309 · cited 5×
“5.11 The second trial, a small, short-term cross over study of L-thyroxine therapy by Nystrom and associates ( 49 ), was in women identified by screen ing in the general population (Table 3). The 20 participants were women older than 50 years of age who had an initial TSH level between 4 and 15 mU/L.”
Influential
Cited by
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Metadata
- Authors
- Helfand, M., & Redfern, C. C.
- Affiliations
- Providence Portland Medical Center (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1998-07-15
- Volume
- 129
- Issue
- 2
- Pages
- 144-158
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2066467884
- Cited by
- 304
- References
- 65
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 9 · 2014: 10 · 2013: 11 · 2012: 12
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid screening, thyroid-stimulating hormone, subclinical hypothyroidism, subclinical hyperthyroidism, primary care, women over 50, screening yield, treatment efficacy
- MeSH terms
- Adult, Female, Humans, Hyperlipidemias, Hyperthyroidism, Hypothyroidism, Mass Screening, Risk Factors, Thyroid Function Tests, Thyrotropin, Thyroxine, Vascular Diseases, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Thyroid Disease: An Update. https://app.cochat.ai/papers/10.7326/0003-4819-129-2-199807150-00020
- The paper
- Helfand, M., & Redfern, C. C. (1998). Screening for Thyroid Disease: An Update. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-129-2-199807150-00020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.